Showing 2381-2390 of 2527 results for "".
- Ocutrx Vision Technologies Receives Second Patent for Augmented Reality Glasses Eye Tracking Technologyhttps://modernod.com/news/ocutrx-vision-technologies-receives-second-patent-for-augmented-reality-glasses-eye-tracking-technology/2476434/Ocutrx Vision Technologies, a manufacturer of augmented reality (AR) glasses, announced the issuance of the company’s second US patent, which will protect the company’s unique eye tracking technology for patients with macular degeneration and other low vision conditions. The patent applies to bot
- Lightmed and Mexico’s Leading Pediatric Hospitals Partner in Childhood Blindness Preventionhttps://modernod.com/news/lightmed-and-mexicos-leading-pediatric-hospitals-partner-in-childhood-blindness-prevention/2476428/Lightmed Corp. announced the successful installation and support of 34 LIGHTLas 810 photocoagulator lasers across 32 Mexican states. Mexico’s Ministry of Health initially purchased 18 Lightmed lasers to be placed in areas with the most urgent need. Soon after, they ordered an additional 16 units
- Orasis Announces Initiation of Phase 2b Clinical Study of CSF-1 for the Treatment of Presbyopiahttps://modernod.com/news/orasis-announces-initiation-of-phase-2b-clinical-study-of-csf-1-for-the-treatment-of-presbyopia/2476421/Orasis Pharmaceuticals announced the initiation of a phase 2b clinical study in the United States evaluating CSF-1 for the treatment of presbyopia. The phase 2b study is a multicenter, double-masked trial in the United States enrolling 150 participants with presbyopia to evaluate the efficacy and
- Study: Excess Hormones Could Cause a Condition That Can Lead to Blindness in Womenhttps://modernod.com/news/study-excess-hormones-could-cause-a-condition-that-can-lead-to-blindness-in-women/2476403/Research led by the University of Birmingham, UK, has found that increased levels of hormones including testosterone could cause a brain condition that can lead to blindness in women. Idiopathic Intracranial Hypertension—also known as IIH—is caused by high pressure in the brain with conseq
- Children’s Hospital Los Angeles Receives $1.6M Grant to Study Retinoblastomahttps://modernod.com/news/childrens-hospital-los-angeles-receives-1-6m-grant-to-study-retinoblastoma/2476397/Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age and accounts for approximately 4% of childhood cancers. If not diagnosed early, retinoblastoma may result in loss of one or both eyes and can be fatal. David Cobrinik, MD, PhD, of The Saban Researc
- Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kithttps://modernod.com/news/q-biomed-and-mannin-research-to-develop-gdf15-biomarker-glaucoma-diagnostic-kit/2476396/Q BioMed announced that its technology partner Mannin Research has entered into a research collaboration with the Biointerfaces Institute at McMaster University in Ontario, Canada to develop a GDF15 biomarker diagnostic kit for monitoring glaucoma severity and progression. This enabling te
- Prevent Blindness Announces Recipient of 2019 Jenny Pomeroy Award for Excellence in Vision and Public Healthhttps://modernod.com/news/prevent-blindness-announces-recipient-of-2019-jenny-pomeroy-award-for-excellence-in-vision-and-public-health/2476374/Prevent Blindness has announced the recipient of the 2019 Jenny Pomeroy Award for Excellence in Vision and Public Health is Cynthia Owsley, PhD, MSPH, Nathan E. Miles Chair of Ophthalmology and Director of the Clinical Research Unit at the University of Alabama at Birmingham (UAB) School of Medic
- EyePoint Pharmaceuticals Announces US Commercial Launch of Dexycuhttps://modernod.com/news/eyepoint-pharmaceuticals-announces-us-commercial-launch-of-dexycu/2476370/EyePoint Pharmaceuticals announced that it has commercially launched Dexycu (dexamethasone intraocular suspension) 9% in the United States. Dexycu is the first and only FDA approved intraocular steroid for the treatment of postoperative inflammation and is administered as a single dose at the end
- Clemson Eye Integrates Two Greenville Eye Care Practices into Its Networkhttps://modernod.com/news/clemson-eye-integrates-two-greenville-eye-care-practices-into-its-network/2476368/This spring, Clemson Eye will unite with two Greenville eye health practices — Montgomery & Riddle Eyecare and Donelson Eye Associates — under the Clemson Eye brand name. Combined, the practices serve more than 100,000 patients and offer more than 10 specialties. “This transition is a
- Telemedicine Eye Screenings Help Detect Glaucomahttps://modernod.com/news/telemedicine-eye-screenings-help-detect-glaucoma/2476356/A low-cost program using technicians to conduct telemedicine eye screenings can help detect glaucoma in underserved populations, according to new research, as reported by Reuters. The study targeted high-risk individuals in poorer a